Free Trial
ETR:BAYN

Bayer Aktiengesellschaft (BAYN) Stock Price, News & Analysis

Bayer Aktiengesellschaft logo
€18.94 +0.07 (+0.37%)
(As of 12/20/2024 ET)

About Bayer Aktiengesellschaft Stock (ETR:BAYN)

Key Stats

Today's Range
€18.57
€19.05
50-Day Range
€18.87
€26.53
52-Week Range
€24.96
€44.28
Volume
7.78 million shs
Average Volume
N/A
Market Capitalization
$18.61 billion
P/E Ratio
N/A
Dividend Yield
0.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. The Crop Science segment offers seeds, improved plant traits, innovative chemical and biological crop protection products, digital solutions, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Receive BAYN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYN Stock News Headlines

Bayer AG Aktie: Attraktive Renditechancen
Bayer-Aktie: Kurs heute im Minus (18,714 €)
Crypto’s hidden gem + greatest crypto bull run in history = $$$?
You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.
Bayer-Medikament Eylea erzielt Studienerfolg
Bayer AG Aktie: Beeindruckende Geschäftsentwicklung!
Bayer AG Aktie: Zeichen stehen schlecht!
Bayer AG Aktie: Herausforderungen bleiben
Bayer: 560-Millionen-Euro-Deal für Herz-Kreislauf-Markt
See More Headlines

BAYN Stock Analysis - Frequently Asked Questions

Bayer Aktiengesellschaft's stock was trading at €33.63 at the start of the year. Since then, BAYN shares have decreased by 43.7% and is now trading at €18.94.
View the best growth stocks for 2024 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bayer Aktiengesellschaft investors own include Hawkins (HWKN), NVIDIA (NVDA), Meta Platforms (META), Alibaba Group (BABA), Basf (BAS), Volkswagen (VOW3) and Bayerische Motoren Werke Aktiengesellschaft (BMW).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - General
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
96,931
Year Founded
N/A

Profitability

Net Income
$-1,270,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$47.11 billion
Cash Flow
€3.31 per share
Book Value
€36.33 per share

Miscellaneous

Free Float
N/A
Market Cap
$18.61 billion
Optionable
Not Optionable
Beta
0.97
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (ETR:BAYN) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners